 |
 |
|||||
  |
 |
 |
 |
 |
 |
|
 |
|
|
FKH is well-versed in the intricacies of biotech IR and the tremendous opportunities and obligations it presents to executives. In addition to helping you build a relationship with the Street and demonstrate your value, we can provide ongoing advice and support for your communications with regulatory bodies, key investors and the financial media. We have assisted numerous biotech companies on the pathway to IPO, managing all communications before, during and after the offering. We can help you develop financing strategies, prepare for financial meetings, manage analyst briefings, comply with SEC disclosure regulations and effectively manage shareholder communications. |
|
||
 |
||||
|
|
|
|
|